Literature DB >> 17655938

Matrix metalloproteinase-9 -1562 C/T gene polymorphism in Serbian patients with multiple sclerosis.

Maja Zivković1, Tamara Djurić, Evica Dincić, Ranko Raicević, Dragan Alavantić, Aleksandra Stanković.   

Abstract

Matrix metalloproteinase-9 (MMP-9) is suggested to play a role in MS by mediating T cell migration across subendothelial basement membrane and by contribution to myelin breakdown. We studied the association of MMP-9 -1562 C/T gene polymorphisms with MS susceptibility and severity in 187 patients from Serbia. The significant decrease in T allele carriership (p = 0.01), was found in female MS patients. In addition, a trend toward lower MSSS in T allele carriers was noticed (CC, mean 5.7 +/- 2.5 vs. CT+TT, mean 4.9 +/- 2.5). Further studies in different populations are needed to resolve the potential influence of MMP-9 gene polymorphism on MS.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17655938     DOI: 10.1016/j.jneuroim.2007.06.022

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  6 in total

Review 1.  The significance of matrix metalloproteinases in the immunopathogenesis and treatment of multiple sclerosis.

Authors:  Abbas Mirshafiey; Babak Asghari; Ghasem Ghalamfarsa; Farhad Jadidi-Niaragh; Gholamreza Azizi
Journal:  Sultan Qaboos Univ Med J       Date:  2014-01-27

2.  Family Analysis of Linkage and Association of HLA-DRB1, CTLA4, TGFB1, IL4, CCR5, RANTES, MMP9 and TIMP1 Gene Polymorphisms with Multiple Sclerosis.

Authors:  O Yu Makarycheva; E Yu Tsareva; M A Sudomoina; O G Kulakova; B V Titov; O V Bykova; N V Gol'tsova; L M Kuzenkova; A N Boiko; O O Favorova
Journal:  Acta Naturae       Date:  2011-01       Impact factor: 1.845

3.  Impact of matrix metalloproteinase 9 rs3918242 genetic variant on lipid-lowering efficacy of simvastatin therapy in Chinese patients with coronary heart disease.

Authors:  Yuanyuan Xu; Yan Wang; Jixin Zhi; Lichun Qi; Tong Zhang; Xueqi Li
Journal:  BMC Pharmacol Toxicol       Date:  2017-04-08       Impact factor: 2.483

4.  Matrix metalloproteinases (MMPs) family gene polymorphisms and the risk of multiple sclerosis: systematic review and meta-analysis.

Authors:  Mina Mohammadhosayni; Arezou Khosrojerdi; Keivan Lorian; Saeed Aslani; Danyal Imani; Bahman Razi; Farhad Babaie; Shahram Torkamandi
Journal:  BMC Neurol       Date:  2020-05-29       Impact factor: 2.474

5.  Association Study between Functional Polymorphisms of MMP9 Gene Promoter and Multiple Sclerosis Susceptibility in an Iranian Population.

Authors:  Sima Sabbagh; Zakiye Nadeali; Leila Dehghani; Vahid Shaygannejad; Majid Rezvani; Masih Saboori; Hamid Ganji; Soheil Tahani; Farzaneh Dehghani; Saman Hosseinzadeh; Elnaz Marzbani; Peiman Shafiei
Journal:  Iran J Public Health       Date:  2019-09       Impact factor: 1.429

6.  Matrix Metalloproteinase-9 (MMP9)-A Mediating Enzyme in Cardiovascular Disease, Cancer, and Neuropsychiatric Disorders.

Authors:  Janusz K Rybakowski
Journal:  Cardiovasc Psychiatry Neurol       Date:  2009-08-31
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.